Novartis CEO says it won't join weight-loss drug frenzy

The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…

Fund manager of names in weight loss and biotechnology

Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…